The Hartford
HIG
$140.78
+1.44%
The Hartford Insurance Group, Inc. is a diversified insurance and financial services company providing property and casualty insurance, group benefits, and mutual funds. It operates through five segments: Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds, with the majority of revenue generated from Business Insurance. As a well-established player in the insurance industry, The Hartford is recognized for service excellence, sustainability, and integrity, positioning it as a trusted provider for both commercial and individual clients. The current investor narrative centers on the company's consistent earnings growth, strong underwriting performance, and capital return strategy, with recent focus on its ability to navigate a competitive pricing environment and maintain margin expansion.…
HIG
The Hartford
$140.78
Investment Opinion: Should I buy HIG Today?
Rating: Hold. The Hartford is a well-run insurer with strong fundamentals and an attractive valuation, but its recent relative underperformance and mixed analyst sentiment suggest limited near-term upside. The analyst consensus leans bullish with an average target of ~$150.28, implying +8.3% upside, but the downgrade by Keefe, Bruyette & Woods tempers enthusiasm.
Supporting Evidence: The trailing P/E of 10.2x is a 32% discount to the industry average of 15x, and the PEG ratio of 0.36x indicates undervaluation relative to growth. Revenue growth of 7.5% YoY is consistent, and operating margin expanded to 19.3% from 15.8%. Free cash flow TTM of $5.753 billion supports a dividend yield of 1.58% and aggressive buybacks. ROE of 20.2% is well above the industry average, demonstrating efficient capital use.
Risks & Conditions: The Hold rating could upgrade to Buy if the stock pulls back to $125 (near 52-week low) or if revenue growth accelerates above 10%. It would downgrade to Sell if gross margins fall below 40% or if the company cuts its dividend. The stock appears undervalued relative to its history and peers, but the relative weakness and competitive pressures justify a cautious stance. This is not personalized financial advice; investors should consider their own risk tolerance.
Sign up to view all
HIG 12-Month Price Forecast
The Hartford offers a compelling value proposition with a low P/E and strong cash generation, but its relative underperformance and mixed analyst sentiment create uncertainty. The base case of steady growth to $150 is most likely, but the stock lacks catalysts for a significant re-rating. Upside would require sustained margin expansion and earnings beats, while downside risks include catastrophe losses and competitive pressure. The neutral stance reflects balanced risk/reward at current levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Hartford's 12-month outlook, with a consensus price target around $183.01 and implied upside of +30.0% versus the current price.
Average Target
$183.01
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$113 - $183
Analyst target range
The stock is covered by 4 analysts, with a consensus leaning bullish: 2 Overweight, 1 Neutral, and 1 Market Perform. The average EPS estimate for the next fiscal year is $15.18, with a low of $14.37 and high of $15.74. The average revenue estimate is $31.14 billion, implying modest growth. The implied upside to the average target is not directly provided, but based on the forward P/E of 9.9x and EPS of $15.18, the target price would be approximately $150.28, representing +8.3% upside from the current price of $138.78. The target range spans from $142.25 (low) to $155.80 (high), indicating a spread of about 9.5%, reflecting moderate uncertainty. The high target assumes continued margin expansion and premium growth, while the low target prices in potential catastrophe losses or competitive pressure. Recent ratings actions show a downgrade by Keefe, Bruyette & Woods from Outperform to Market Perform in March 2026, while other firms like Wells Fargo and Cantor Fitzgerald maintain Overweight ratings, suggesting mixed sentiment but overall constructive outlook.
Bulls vs Bears: HIG Investment Factors
The Hartford presents a mixed picture with strong fundamentals—consistent revenue growth, expanding margins, and a robust capital return program—offset by relative underperformance and mixed analyst sentiment. The bull case is supported by a compelling valuation (P/E 10.2x vs industry 15x) and defensive characteristics (beta 0.47), while the bear case centers on competitive pressures and catastrophe risk. The single most important tension is whether the company can sustain its underwriting margin expansion and revenue growth in a competitive pricing environment. Currently, the evidence slightly favors the bull case due to the attractive valuation and strong cash generation, but the stock's recent relative weakness warrants caution.
Bullish
- Strong Underwriting Profitability: Gross margin improved dramatically to 48.9% in Q4 2025 from 15.6% a year ago, reflecting better underwriting and lower loss ratios. Operating margin expanded to 19.3% from 15.8%, indicating strong cost control and pricing discipline.
- Consistent Revenue Growth: Revenue grew 7.5% YoY in Q4 2025 to $7.312 billion, with accelerating growth over the past four quarters from 6.4% to 8.0%. This is driven by strong premium retention and new business in commercial lines.
- Attractive Valuation with Low P/E: Trailing P/E of 10.2x and forward P/E of 9.9x represent a 32% discount to the industry average of 15x. The PEG ratio of 0.36x suggests the stock is undervalued relative to its earnings growth rate.
- Robust Capital Return to Shareholders: The company returned $1.366 billion to shareholders in Q4 2025 through dividends ($0.151B) and buybacks ($1.215B). Free cash flow TTM is $5.753 billion, providing ample capacity for continued returns.
Bearish
- Relative Underperformance vs Market: The stock's 1-year return of +13.8% lags the S&P 500's +20.6%, resulting in a relative strength of -6.8%. Over 3 months, relative underperformance is -10.0%, indicating persistent weakness.
- Mixed Analyst Sentiment with Downgrade: Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform in March 2026. While 2 of 4 analysts rate it Overweight, the downgrade signals caution on near-term prospects.
- Potential Catastrophe Loss Exposure: As a P&C insurer, The Hartford is exposed to catastrophe losses that could pressure underwriting margins. The low P/E of 10.2x may reflect market concerns about such events, which are unpredictable.
- Competitive Pressure in Personal Lines: While commercial lines are strong, personal lines face competitive pressure that could limit growth. Revenue growth of 7.5% is solid but may decelerate if pricing competition intensifies.
HIG Technical Analysis
The Hartford's stock is in a sustained uptrend, with a 1-year price change of +13.8%, outperforming the broader market's 20.6% gain but showing relative weakness. The current price of $138.78 is at 96% of its 52-week range ($119.61-$144.50), indicating the stock is near its highs and reflecting positive momentum but also potential overextension. The stock's beta of 0.47 suggests it is significantly less volatile than the market, appealing for risk-averse investors. Short-term momentum is mixed: the 1-month change is +7.4%, accelerating sharply from the 3-month change of +1.1%, suggesting a recent bullish push. However, the 1-year trend of +13.8% is below the 3-month trend of +1.1%, indicating a deceleration in longer-term momentum. The divergence between the strong 1-month performance and weaker 1-year relative strength (-6.8% vs SPY) could signal a short-term recovery within a broader underperformance trend. The 52-week high of $144.50 acts as key resistance; a breakout above this level would signal renewed bullish momentum and potential for further upside. The 52-week low of $119.61 provides strong support; a breakdown below this level would indicate a bearish reversal. With a beta of 0.47, the stock is 53% less volatile than the S&P 500, making it a defensive holding with lower risk.
Beta
0.47
0.47x market volatility
Max Drawdown
-12.3%
Largest decline past year
52-Week Range
$120-$145
Price range past year
Annual Return
+16.4%
Cumulative gain past year
| Period | HIG Return | S&P 500 |
|---|---|---|
| 1m | +8.6% | +1.0% |
| 3m | +1.4% | +7.9% |
| 6m | +6.7% | +8.5% |
| 1y | +16.4% | +20.1% |
| ytd | +2.7% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HIG Fundamental Analysis
Revenue has been growing steadily, with the most recent quarter (Q4 2025) reporting $7.312 billion, up 7.5% year-over-year from $6.8 billion in Q4 2024. The multi-quarter trend shows accelerating growth: Q1 2025 revenue was $6.81 billion (+6.4% YoY), Q2 2025 $6.987 billion (+8.0% YoY), Q3 2025 $7.232 billion (+7.7% YoY), and Q4 2025 $7.312 billion (+7.5% YoY). The consistent mid-single-digit growth is driven by strong premium retention and new business in commercial lines, though personal lines face competitive pressure. The company is highly profitable, with net income of $1.131 billion in Q4 2025 and a net margin of 15.5%. Gross margin improved to 48.9% in Q4 2025 from 15.6% in Q4 2024, reflecting better underwriting and lower loss ratios. Operating margin expanded to 19.3% from 15.8% a year ago, indicating strong cost control and pricing discipline. The balance sheet is robust: debt-to-equity ratio is low at 0.23, and free cash flow for the trailing twelve months is $5.753 billion, providing ample liquidity. Return on equity (ROE) stands at 20.2%, well above the industry average, demonstrating efficient capital utilization. The company generates strong operating cash flow ($1.808 billion in Q4 2025) and consistently returns capital to shareholders via dividends ($0.151 billion in Q4) and share buybacks ($1.215 billion in Q4).
Quarterly Revenue
$7.3B
2025-12
Revenue YoY Growth
+7.53%
YoY Comparison
Gross Margin
48.95%
Latest Quarter
Free Cash Flow
$5.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HIG Overvalued?
Since net income is positive ($1.131 billion in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E is 10.2x, while the forward P/E is 9.9x, implying modest earnings growth expectations. The gap between trailing and forward P/E suggests the market anticipates stable earnings, with a slight expansion. Compared to the industry average P/E of approximately 15x (based on sector data), The Hartford trades at a 32% discount, reflecting its lower growth profile but also its consistent profitability and defensive nature. The PEG ratio of 0.36x indicates the stock is undervalued relative to its earnings growth rate, suggesting potential upside. Historically, the trailing P/E of 10.2x is near the low end of its 5-year range (which has fluctuated between 6x and 14x), implying the stock is relatively cheap compared to its own history. This low valuation may reflect market concerns about catastrophe losses or competitive pressures, but it also presents a value opportunity if the company maintains its earnings trajectory.
PE
10.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~24x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The Hartford's debt-to-equity ratio is low at 0.23, and free cash flow TTM of $5.753 billion provides ample liquidity. However, net margin of 15.5% is sensitive to underwriting performance; a spike in catastrophe losses could compress margins. The payout ratio of 16% is conservative, but the reliance on share buybacks ($1.215B in Q4) means reduced buyback activity could pressure EPS growth. Revenue concentration in Business Insurance (majority of revenue) exposes the company to commercial lines cycle risk.
Market & Competitive Risks: The stock's beta of 0.47 makes it less sensitive to macro swings, but its relative underperformance (-6.8% vs SPY over 1 year) suggests sector rotation away from insurers. Valuation compression risk is low given the already discounted P/E of 10.2x, but if the industry average P/E contracts, HIG could fall further. Competitive pressure in personal lines and the downgrade by Keefe, Bruyette & Woods highlight emerging threats. The stock's low short ratio of 0.05 indicates minimal bearish sentiment, but this could change if earnings disappoint.
Worst-Case Scenario: A severe catastrophe event combined with a broad market downturn could drive the stock to its 52-week low of $119.61, representing a -13.8% decline from the current price of $138.78. In a prolonged bear market, the stock could test the $119.61 support, and if broken, further downside to $110 (historical support) is possible, implying a -20.7% loss. The max drawdown of -12.26% over the past year provides a reference for potential downside.
FAQ
The key risks are: 1) Catastrophe losses – as a P&C insurer, a major hurricane or wildfire could significantly impact underwriting margins and earnings. 2) Competitive pressure – personal lines face pricing competition that could slow revenue growth and compress margins. 3) Relative underperformance – the stock has lagged the market by 6.8% over the past year, and if this persists, it may continue to underperform. 4) Analyst downgrade risk – the recent downgrade by Keefe, Bruyette & Woods could be followed by others if fundamentals deteriorate. The most severe risk is a catastrophe event that could drive the stock to its 52-week low of $119.61, a -13.8% decline.
The 12-month forecast is balanced with a base case of gradual appreciation to $140-$150 (55% probability), driven by steady revenue growth and stable margins. The bull case (25% probability) targets $150-$160, assuming strong underwriting results and a P/E re-rating. The bear case (20% probability) sees the stock falling to $120-$130 if catastrophe losses or competitive pressures hurt earnings. The analyst average target of $150.28 implies +8.3% upside. The most likely scenario is the base case, where the stock trades near its current P/E and delivers modest returns in line with earnings growth.
HIG appears undervalued based on multiple metrics. The trailing P/E of 10.2x is well below the industry average of 15x and near the low end of its 5-year range (6x-14x). The forward P/E of 9.9x implies modest earnings growth expectations. The PEG ratio of 0.36x suggests the stock is cheap relative to its growth rate. The price-to-book ratio of 2.05x is reasonable for an insurer with a 20.2% ROE. The market is pricing in concerns about catastrophe risk and competitive pressures, but the company's consistent profitability and strong cash flow argue for a higher multiple. Overall, HIG is undervalued relative to peers and its own history.
The Hartford is a good buy for value-oriented, risk-averse investors seeking steady income and capital appreciation. The stock trades at a trailing P/E of 10.2x, a 32% discount to the industry average of 15x, and offers a dividend yield of 1.58% supported by strong free cash flow. Analyst targets imply +8.3% upside to $150.28, but the stock has underperformed the market over the past year. The biggest downside risk is a major catastrophe event that could pressure margins. For long-term investors with a 3-5 year horizon, the current valuation provides a margin of safety. However, short-term traders may find limited catalysts for immediate gains.
HIG is better suited for long-term investment due to its low beta (0.47), consistent dividend payments, and value-oriented profile. The stock's low volatility makes it less attractive for short-term trading, as it lacks the price momentum of growth stocks. The dividend yield of 1.58% and share buybacks provide total return potential over time. A minimum holding period of 3-5 years is recommended to allow the valuation discount to close and earnings growth to compound. Short-term traders may find limited opportunities given the stock's narrow trading range and lack of catalysts.